The magnitude of adherence to option B plus program and associated factors among women in eastern African countries: a systematic review and meta-analysis [PDF]
Background Despite coverage and benefits associated with the prevention of mothers to child transmission (PMTCT) services, mothers’ adherence to option B plus is still a challenge. Though few primary studies are available on the magnitude of adherence to
Reta Tsegaye +5 more
doaj +3 more sources
Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study [PDF]
The acceptability of lifelong antiretroviral therapy (ART) among HIV-positive women in high-burden Nigeria, is not well-known. We explored readiness of users and providers of prevention of mother-to-child transmission of HIV (PMTCT) services to accept ...
Salome C. Erekaha +8 more
doaj +3 more sources
Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia [PDF]
Background Adherence to Option B plus Antiretroviral Therapy plays a vital role in preventing mother to child transmission of Human Immunodeficiency Virus and development of drug resistance.
Dawit Jember Tesfaye +9 more
doaj +4 more sources
A qualitative study on reasons for women’s loss and resumption of Option B plus care in Ethiopia [PDF]
Loss to follow-up (LTFU) from Option B plus, a lifelong antiretroviral therapy (ART) for pregnant women living with human immunodeficiency virus (HIV), irrespective of their clinical stage and CD4 count, threatens the elimination of vertical transmission
Wolde Facha +3 more
doaj +3 more sources
Level of option B plus drug adherence for preventing mother-to-child transmission of HIV and associated factors among HIV-positive women in the awi zone, amhara region, northwest Ethiopia,2020 [PDF]
Introduction: Adherence to Option B+ antiretroviral medication (ART) is essential for the successful implementation of the Prevention of Mother-to-Child Transmission (PMTCT) program.
Tegegne Wale Belachew +5 more
doaj +4 more sources
Level of adherence to option B plus PMTCT and associated factors among HIV positive pregnant and lactating women in public health facilities of Hawassa city, Southern Ethiopia. [PDF]
BackgroundAdherence to antiretroviral therapy is very essential to achieve a great outcome of drugs via suppressing viral load, preventing multidrug resistance, and reducing mother to a child transmission rate of the Human Immune Virus.ObjectiveThis ...
Samuel Abdisa, Zelalem Tenaw
doaj +3 more sources
Alarm Clock-Based Reminder for Improving Low Adherence on Option B Plus Antiretroviral Therapy Among HIV Positive Pregnant and Lactating Mothers in Northern Ethiopia [PDF]
Gebremedhin Gebreegziabher Gebretsadik,1 Hailay Gebretnsae,2 Mulu Ftwi,1 Afewerki Tesfahunegn3 1Department of Midwifery, College of Health Science, Adigrat University, Adigrat, Tigray, Ethiopia; 2Tigray Health Research Institute, Mekelle, Tigray ...
Gebretsadik GG +3 more
doaj +2 more sources
Increasing retention of HIV positive pregnant and breastfeeding mothers on option-b plus by upgrading and providing full time HIV services at a lower health facility in rural Uganda [PDF]
Background Despite advancement in Prevention of Mother to Child Transmission (PMTCT) services, the rate of MTCT of HIV in sub-Saharan Africa is still high. This is partly due to low retention of HIV positive mothers in HIV care.
Enosk Mirembe Masereka +5 more
doaj +2 more sources
Early Diagnosis of HIV among Infants Born to HIV-Positive Mothers on Option-B Plus in Kampala, Uganda [PDF]
Introduction. Globally, there is delay in accessing early HIV diagnosis (EID) among HIV exposed infants (HEIs). With paucity of data on EID use at Kisenyi Health Center, this study assessed factors associated with EID use among HEIs (HIV exposed infants).
Jonathan Izudi +2 more
doaj +2 more sources
Pirtobrutinib Monotherapy for First-Line Chronic Lymphocytic Leukemia: A Non-Anchored Indirect Comparison Using Reconstructed Patient-Level Data [PDF]
Background: Pirtobrutinib has recently emerged as a promising first-line treatment option for chronic lymphocytic leukemia (CLL). Unlike currently established regimens, which are generally based on doublet combinations, pirtobrutinib can be administered ...
Andrea Messori +3 more
doaj +2 more sources

